Improved precision in the analysis of randomized trials with survival outcomes, without assuming proportional hazards

Iván Díaz (), Elizabeth Colantuoni, Daniel F. Hanley and Michael Rosenblum
Additional contact information
Iván Díaz: Weill Cornell Medicine
Elizabeth Colantuoni: Johns Hopkins Bloomberg School of Public Health
Daniel F. Hanley: Johns Hopkins Medical Institutions
Michael Rosenblum: Johns Hopkins Bloomberg School of Public Health

Lifetime Data Analysis: An International Journal Devoted to Statistical Methods and Applications for Time-to-Event Data, 2019, vol. 25, issue 3, No 3, 439-468

Abstract: Abstract We present a new estimator of the restricted mean survival time in randomized trials where there is right censoring that may depend on treatment and baseline variables. The proposed estimator leverages prognostic baseline variables to obtain equal or better asymptotic precision compared to traditional estimators. Under regularity conditions and random censoring within strata of treatment and baseline variables, the proposed estimator has the following features: (i) it is interpretable under violations of the proportional hazards assumption; (ii) it is consistent and at least as precise as the Kaplan–Meier and inverse probability weighted estimators, under identifiability conditions; (iii) it remains consistent under violations of independent censoring (unlike the Kaplan–Meier estimator) when either the censoring or survival distributions, conditional on covariates, are estimated consistently; and (iv) it achieves the nonparametric efficiency bound when both of these distributions are consistently estimated. We illustrate the performance of our method using simulations based on resampling data from a completed, phase 3 randomized clinical trial of a new surgical treatment for stroke; the proposed estimator achieves a 12% gain in relative efficiency compared to the Kaplan–Meier estimator. The proposed estimator has potential advantages over existing approaches for randomized trials with time-to-event outcomes, since existing methods either rely on model assumptions that are untenable in many applications, or lack some of the efficiency and consistency properties (i)–(iv). We focus on estimation of the restricted mean survival time, but our methods may be adapted to estimate any treatment effect measure defined as a smooth contrast between the survival curves for each study arm. We provide R code to implement the estimator.

Keywords: Covariate adjustment; Efficiency; Targeted minimum loss based estimation; Random censoring (search for similar items in EconPapers)
Date: 2019
References: View references in EconPapers View complete reference list from CitEc
Citations: View citations in EconPapers (4)

Downloads: (external link)
http://link.springer.com/10.1007/s10985-018-9428-5 Abstract (text/html)
Access to the full text of the articles in this series is restricted.

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:spr:lifeda:v:25:y:2019:i:3:d:10.1007_s10985-018-9428-5

Ordering information: This journal article can be ordered from
http://www.springer.com/journal/10985

DOI: 10.1007/s10985-018-9428-5

Access Statistics for this article

Lifetime Data Analysis: An International Journal Devoted to Statistical Methods and Applications for Time-to-Event Data is currently edited by Mei-Ling Ting Lee

More articles in Lifetime Data Analysis: An International Journal Devoted to Statistical Methods and Applications for Time-to-Event Data from Springer
Bibliographic data for series maintained by Sonal Shukla () and Springer Nature Abstracting and Indexing ().